ESR1 and cancer: However, in cancer cells it has been shown that ER transcriptional activity can occur in a ligand-independent manner secondary to the overexpression of certain coactivators (i.e. SRC3) or increased activity of signaling pathways which impinge upon the ER-coregulator complex9.